Ads
related to: pfizerrxrs.com has been visited by 10K+ users in the past month
Search results
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 1 day agoTwo of these ultra-high-yield S&P 500 dividend stocks are nothing short of screaming buys right now....
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 5 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 18 hours agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 2 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
The Highest Paid CEOs of 2023
The Wall Street Journal· 1 day agoBottom of the pack Among the 25 worst-performing companies in the Journal analysis, nearly a third operated in the healthcare sector, including six...
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoIf you have an extra $100 to invest, you could set yourself up with dividends from Realty Income...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga· 2 days agoA Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters via AOL· 5 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 2 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Ad
related to: pfizerrxrs.com has been visited by 10K+ users in the past month